c-LEcta is a leading industrial biotech company specialised on the discovery, optimisation and production of best-in-class enzymes, and on strain engineering for protein and small molecule production.
c-LEcta GmbH was established in September 2004 as a spin-off from the University of Leipzig. To date, c-LEcta shaped into a leading industrial biotech company and provides customised, best-in-class enzymes and microbial strains for the production of high value products for industrial needs. Thereby c-LEcta constantly improves its own proprietary technologies and processes as well as supports industrial partners in existing and new markets. The profound knowledge and expertise of about 50 employees in the fields of discovery, optimisation and production of enzymes as well as engineering of diverse microbial strains lead to more than five successfully launched products in collaboration with top tier industry partners. c-LEcta’s contribution to cost-efficient and sustainable production processes are of great importance to regulated industrial sectors like pharma and food.
The company has developed several proprietary methods for the identification of new enzymes from natural biodiversity, the optimisation of enzymes for industrial processes and the development of efficient enzyme production processes. The enzyme development platform of c-LEcta has been developed over the last 10 years following the primary objective of fast access to the optimal biocatalyst in a streamlined manner. The platform consists of unique and proprietary methods like cluster screening, c-LEcta mutagenesis and bioinformatics tools. Our methods are featured by high quality and reliability, thus resulting in excellent hit rate in enzyme libraries and speed in enzyme development projects. The success of c-LEcta’s enzyme engineering platform has been demonstrated over the last 10 years for various enzyme classes and engineering objectives.
Find out more about c-LEcta here.
Manchester, United Kingdom
La Coruña, Spain
York, United Kingdom